Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06336850 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
A NA study of Liver Diseases, sponsored by Methodist Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06336850: Recruiting NA study of Liver Diseases, sponsored by Methodist Health System.
NCT06336850 is a NA study of Liver Diseases that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 100 participants, below the 61,155-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06336850, a NA study of Liver Diseases, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.
Primary Outcome
A catheter is inserted into the hepatic vein before hepatic venous pressure and portal vein pressure are recorded
Conditions Studied
Interventions
- PROCEDURE Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
What NCT06336850 shows while recruiting
NCT06336850 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 61,155-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement is the first listed.
NCT06336850 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06336850 about?
NCT06336850 is a clinical study titled "Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement". The purpose of this study is to evaluate the efficacy, safety, and adequacy of Endoscopic Ultrasound (EUS) Portal Pressure Gradient Measurement (PPGM) in patients undergoing EUS-guided liver biopsies.
What is the current status of trial NCT06336850?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-12-23. Estimated completion is 2025-01-01.
What conditions does trial NCT06336850 study?
This clinical trial studies the following conditions: Liver Diseases.
What interventions are being tested in trial NCT06336850?
The interventions under investigation include: Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement (PROCEDURE).
Who is sponsoring clinical trial NCT06336850?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06336850 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06336850's enrollment target sits among peer trials
100 19th of 33 higher than 15 of 33 other Liver Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
RECRUITING · NA
-
Liver Cancer Prevention Randomized Control Trial
ACTIVE NOT RECRUITING · NA
-
Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI